Good Clinical Research Practice (GCRP) in pharmacodynamic studies of neuromuscular blocking agents
- 1 January 1996
- journal article
- review article
- Published by Wiley in Acta Anaesthesiologica Scandinavica
- Vol. 40 (1) , 59-74
- https://doi.org/10.1111/j.1399-6576.1996.tb04389.x
Abstract
Based on an international consensus conference held in Copenhagen in the autumn of 1994, a set of guidelines for Good Clinical Research Practice (GCRP) in pharmacodynamic studies of neuromuscular blocking agents are presented. The guidelines are intended to be a help for people working in this research field, and it is hoped that the guidelines will assist researchers, editors, and drug companies to enhance the quality of their pharmacodynamic studies of neuromuscular blocking agents.Keywords
This publication has 40 references indexed in Scilit:
- Clinical Pharmacokinetics of Drugs in ObesityClinical Pharmacokinetics, 1993
- Pharmacokinetics and Pharmacodynamics of Vecuronium in the Obese Surgical PatientAnesthesia & Analgesia, 1992
- Assessment of neuromuscular transmission by the evoked acceleration responseActa Anaesthesiologica Scandinavica, 1988
- Onset of action of relaxantsCanadian Journal of Anesthesia/Journal canadien d'anesthésie, 1988
- Comparison between a new acceleration transducer and a conventional force transducer in the evaluation of twitch responsesActa Anaesthesiologica Scandinavica, 1988
- The acceleration transducer – an assessment of its precision in comparison with a force displacement transducerActa Anaesthesiologica Scandinavica, 1988
- Posttetanic Count (PTC)Anesthesiology, 1981
- Human Dose–Response Curves for Neuromuscular Blocking DrugsAnesthesiology, 1980
- Pancuronium BromideAnesthesia & Analgesia, 1973
- EXPERIMENTAL AND CLINICAL EXPERIENCES WITH A NEW MUSCLE RELAXANT Ro 4–3816, DIALLYL‐NOR‐TOXIFERINEActa Anaesthesiologica Scandinavica, 1962